Larimar Therapeutics, Inc.

LRMR Healthcare Biotechnology

In the quarter to June 2026, EPS grew 26.8% and free cash flow fell 127.6%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

1.99 0.00 0.00%
Market cap
$206.7M
P/E
0.0×
Fwd P/E
—
Dividend yield
—
F-score
n/a
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '25 Dec '24 Dec '23 Dec '22 Jan '22 Dec '21 Jan '21 Dec '20 Jan '20 Dec '19
Cash and Short Term Investments
136.85 183.45 86.79 118.43 — 70.10 — 92.64 — 1.01
Total current assets
142.02 195.30 90.18 120.74 — 72.20 — 97.95 — 4.75
Property, Plant, Equpment (Net)
0.62 0.88 0.68 0.83 — 1.05 — 1.04 — 0.27
Long-term assets (Other)
1.13 1.20 2.00 1.98 — 2.01 — 1.76 — 0.09
Total non-current assets
3.82 4.92 5.76 5.67 — 6.46 — 6.73 — 0.45
Total Assets
145.84 200.23 95.94 126.41 — 78.67 — 104.69 — 5.20
Notes Payable
— — — — — — — — — 7.27
Accounts Payable
5.22 2.42 1.28 1.69 — 1.66 — 2.63 — 3.54
Accrued Expenses
58.47 20.87 7.39 8.41 — 6.59 — 5.84 — 2.26
Total current liabilities
64.80 24.36 9.51 10.71 — 8.85 — 8.99 — 5.90
Total non-current liabilities
2.96 4.06 4.71 4.80 — 5.41 — 6.00 — 14.92
Total liabilities
67.76 28.41 14.22 15.50 — 14.25 — 14.99 — 5.90
Additional Paid In Capital
512.78 440.76 270.15 262.50 — 180.65 — 155.29 — 22.43
Common Stock (Net)
0.08 0.06 0.04 0.04 — 0.02 — 0.02 — 0.01
Retained Earnings
(434.83) (269.16) (188.55) (151.60) — (116.25) — (65.61) — (23.13)
Common Equity (Total)
78.09 171.81 81.72 110.90 — 64.41 — 89.69 — (0.69)
Shareholders Equity (Total)
78.09 171.81 81.72 110.90 — 64.41 — 89.69 — (0.69)
Shareholders Equity and Liabilities (Total)
145.84 200.23 95.94 126.41 — 78.67 — 104.69 — 5.20
Shares (Common)
83.09 63.82 43.91 43.27 — 17.71 — 15.37 — 6.09
Shareholders Equity (Tangible)
78.09 171.81 81.72 110.90 — 64.41 — 89.69 — (0.69)
Net Debt
(136.85) (183.45) (86.79) (118.43) (113.63) (70.10) (64.69) (92.64) (86.64) (1.01)
Total Debt
— — — — 4.80 — 5.41 — 6.00 8.46

Fold the line items

In millions of $ except per-share values · columns are period end dates